Diagnosis often involves a combination of clinical evaluation, imaging studies, and genetic testing. MRI scans can reveal the absence or underdevelopment of the corpus callosum. Genetic testing can confirm mutations in the SLC12A6 gene. Early diagnosis is crucial for managing symptoms and improving the quality of life for affected individuals.